The Role of Exosomes in Pancreatic Ductal Adenocarcinoma Progression and Their Potential as Biomarkers

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive and lethal malignancy with a dismal five-year survival rate. Despite remarkable improvements of cancer therapeutics in recent years, patients with PDAC barely benefit from them due to late diagnosis of the disease. Exosomes, sm...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Sheng-Kai, Jadhao, Mahendra, Liao, Wei-Ting, Chang, Wen-Tsan, Lin, I-Ling, Chiu, Chien-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046651/
https://www.ncbi.nlm.nih.gov/pubmed/36980662
http://dx.doi.org/10.3390/cancers15061776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046651/
https://www.ncbi.nlm.nih.gov/pubmed/36980662
http://dx.doi.org/10.3390/cancers15061776

Ejemplares similares